Invesaro

Stocks ATXG Financial statements

Financial statements

ADDENTAX GROUP CORP. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ADDENTAX GROUP CORP. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue5.3413.41010.224.712.77.945.154.185.37
Cost of revenue5.08128.748.7925.910.66.14.043.554.61
Gross profit0.261.441.281.39-1.192.061.841.120.630.76
Selling and marketing0.010.030.020.010.410.210.080.130.390.02
General and administrative0.621.671.952.242.011.912.232.122.062.26
Operating expenses0.631.71.972.252.422.122.32.252.452.29
Operating income-0.37-0.26-0.68-0.86-3.61-0.06-0.46-1.13-1.82-1.53
Interest expense0.020.020.011.513.651.150.61
Interest income000.01
Other non-operating income0.020.020.01-0.080.060.160.32-0.310.210.52
Pre-tax income-0.36-0.69-0.69-0.96-3.560.11.34-3.1-5.09-4.93
Income tax0.010.020.010.020.030.020.020.0100
Income from continuing operations-0.03
Net income to minority interests0
Net income-0.37-0.71-0.69-0.98-3.590.081.32-3.11-5.09-4.47
EBITDA-0.34-0.14-0.57-0.75-3.510.1-0.12-0.8-1.7-1.45
EPS, basic0.000.30-0.30-0.60-2.100.000.60-10.65-12.75-6.27
EPS, diluted0.000.30-0.30-0.60-2.100.000.60-10.65-12.75-6.27
Shares, basic (weighted)502.532.531.691.721.782.020.290.40.71
Shares, diluted (weighted)502.532.531.691.721.782.380.290.40.71

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents0.180.260.280.531.851.390.560.820.320.57
Receivables4.783.421.84.54.762.161.862.110.930.77
Inventory0.450.240.320.350.270.270.290.060.170.18
Other current assets0.050.010.010.030.053.5
Total current assets6.956.392.8685.692329.229.822.9
Property, plant and equipment0.660.650.690.590.790.840.650.570.390.34
Lease right-of-use assets0.61.849.636.530.2719.818.7
Goodwill0.930.480.485.99
Total assets8.557.523.978.4218.413.141.352.349.229.3
Accounts payable1.611.550.883.623.121.330.270.360.050.73
Accrued liabilities0.090.260.230.681.450.611.371.860.42
Deferred revenue0.291.560.10.020000.20.330.05
Short-term debt0.220.350.150.150.140.440.640.67
Total current liabilities8.798.625.6710.112.410.43.534.583.953.06
Lease liabilities1.396.082.770.1518.717.8
Total liabilities8.798.625.6711.518.513.217.226.327.47.57
Paid-in capital-0.410.060.060.066.826.8229.534.535.240
Retained earnings-0.37-1.08-1.78-3.23-6.83-6.76-5.45-8.57-13.7-18.1
Other comprehensive income0.02-0.13-0.030.06-0.1-0.17-0.020.060.11-0.06
Shareholders' equity-0.24-1.1-2.18-3.07-0.08-0.0724.12621.721.8
Minority interests-0.12
Total equity-0.24-1.1-2.18-3.07-0.08-0.0724.12621.721.7
Total liabilities and equity8.557.523.978.4218.413.141.352.349.229.3
Shares outstanding502.532.531.781.781.782.360.360.40.78

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income-0.37-0.71-0.69-0.98-3.590.081.32-3.11-5.09-4.47
Depreciation and amortization0.030.110.120.110.10.160.340.330.120.08
Stock-based compensation0.07
Change in receivables-0.781.361.62-2.7-0.372.590.31-0.250.770.12
Change in inventory0.020.21-0.08-0.030.070-0.020.22-0.11-0.01
Change in payables0.22-0.06-0.612.74-0.27-1.79-1.260.09-0.310.7
Cash from operations0.561.881.19-1.15-4.221.09-1.57-0.410.82-0.6
Capital expenditures-0.1-0.23-0.14-0.41-0.2-0.14-0.2-0.18
Acquisitions0.22
Purchases of investments-17.5
Cash from investing0.23-3.12-0.23-0.14-0.56-0.2-21.20.09-0.21-0.3
Stock issued06.7422.70.65
Cash from financing-0.611.32-0.951.566.1-1.3721.80.52-1.11.15
Exchange rate effect00.01-00.03
Net change in cash0.180.080.020.271.31-0.48-0.890.2-0.490.25
Free cash flow1.780.96-1.29-4.630.89-0.550.62-0.78
Interest paid0.010.02000.030.050.04
Income taxes paid0.010.020.030.020.020.0100

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $3.60 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin12.3%Gross profit / revenue.
Operating margin-23.2%Operating income / revenue.
EBITDA margin-21.6%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-30.2%Pre-tax income / revenue.
Net margin-21.1%Net income / revenue.
FCF margin-3.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-2.1%Cash from operations / revenue.
Return on equity (ROE)-6.6%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-4.9%Net income / average total assets.
Return on invested capital (ROIC)-5.9%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Capex / revenue1.3%Capital expenditures / revenue.
D&A / revenue1.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y28.5%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-12.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-26.3%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y19.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-25.6%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y-174.0%Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y-226.9%Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y0.3%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-3.3%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y-40.5%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-10.9%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y9.7%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y78.5%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-33.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-16.2%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio3.71xCurrent assets / current liabilities.
Quick ratio0.19x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.10x(Cash + short-term investments) / current liabilities.
Liabilities / assets25.9%Total liabilities / total assets.
Interest coverage-45.8xOperating income / interest expense.
Working capital$20.0MCurrent assets - current liabilities.
Goodwill and intangibles / assets18.1%(Goodwill + intangible assets) / total assets.
Tangible book value$19.2MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.23xRevenue / average total assets.
Fixed asset turnover18.5xRevenue / average property, plant and equipment.
Inventory turnover37.8xCost of revenue / average inventory.
Days inventory10 days365 x average inventory / cost of revenue.
Receivables turnover12.4xRevenue / average receivables.
Days sales outstanding29 days365 x average receivables / revenue.
Days payables35 days365 x average accounts payable / cost of revenue.
Cash conversion cycle4 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$2.07Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$9.77Revenue / diluted weighted shares.
FCF per share-$0.34Free cash flow / diluted weighted shares.
Operating cash flow per share-$0.21Cash from operations / diluted weighted shares.
Book value per share$24.65Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$18.65Tangible book value / shares outstanding.
Cash per share$0.74(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$4.2MShare price x shares outstanding.
Enterprise value$3.5MMarket cap + total debt - cash - short-term investments.
P/S0.53xMarket cap / revenue.
P/B0.17xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book0.22xMarket cap / tangible book value, when positive.
EV/Sales0.44xEnterprise value / revenue.
FCF yield-6.5%Free cash flow / market cap.
Earnings yield-39.8%Net income / market cap (the inverse of P/E).
What was ADDENTAX GROUP CORP.'s revenue in fiscal 2026?

ADDENTAX GROUP CORP. reported revenue of $5.4M for fiscal 2026, 28.5% higher than the year before.

Was ADDENTAX GROUP CORP. profitable in fiscal 2026?

No. It reported a net loss of $4.5M.

How much free cash flow did ADDENTAX GROUP CORP. generate in fiscal 2026?

Cash from operations of $603.6K minus capital expenditures of $180.9K left free cash flow of -$784.5K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ADDENTAX GROUP CORP.